Today: 21 May 2026
Browse Category

NASDAQ:VERI 15 October 2025 - 3 December 2025

Veritone (VERI) Stock News and Forecast on December 3, 2025: Analyst Upgrades, Debt Reset and AI Growth Story

Veritone (VERI) Stock News and Forecast on December 3, 2025: Analyst Upgrades, Debt Reset and AI Growth Story

Veritone shares closed at $5.30 on December 3, up 5% after a 17% surge the previous day. Needham reiterated a “Buy” rating with a $10 target, while D. Boral Capital reaffirmed “Buy” with a $23 target. The stock has gained nearly 195% in six months but remains below its 52-week high of $9.42. Analyst consensus is “Moderate/Strong Buy” with an average target near $10.
3 December 2025
·
Veritone (NASDAQ: VERI) Stock Soars 50% on Hyperscaler AI Deals – Key Q3 Highlights & Outlook

Veritone (NASDAQ: VERI) Stock Soars 50% on Hyperscaler AI Deals – Key Q3 Highlights & Outlook

Veritone shares jumped over 50% in after-hours trading Oct. 14, reaching $8.36 after announcing major AI contracts with leading cloud hyperscalers. Preliminary Q3 revenue rose about 30% to $28.5–28.7 million, while the projected non-GAAP net loss narrowed to $5.5–6.0 million. The stock is near a new 52-week high and analysts maintain a “Strong Buy” rating. Final Q3 results are due Nov. 6.
15 October 2025
···

Stock Market Today

  • Lumentum Stock Analysis: Buy or Hold Amid Rising Demand and AI Growth
    May 20, 2026, 10:40 PM EDT. Lumentum is experiencing soaring demand as it supplies critical technology used by industry giants Nvidia and Intel. Despite this growth, The Motley Fool's Stock Advisor did not include Lumentum in its latest top 10 stock picks. Stock Advisor's selections have historically outperformed the market, with average returns of 990% versus 206% for the S&P 500, highlighting the significance of their recommendations. Investors should weigh Lumentum's current prospects against these insights before making decisions. The company remains a key player in AI-driven tech, but cautious evaluation is advised amid competitive recommendations.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop